Evidence map›Paper›PMID 37424558›Full record

ArticleAccess microbiology2023

First report of a carbapenemase OXA-48-producing

Laura Sevillano, Cristhian Herrera, Álvaro Valdes, Ángela de la Hoz, Laura Cardeñoso, Diego Domingo, Maria Auxiliadora Semiglia

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Access microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura SevillanoServicio de Microbiología, Hospital Universitario de La Princesa, Madrid, Spain.ORCID https://orcid.org/0000-0002-8416-0786
Cristhian HerreraServicio de Microbiología, Hospital Universitario de La Princesa, Madrid, Spain.
Álvaro ValdesServicio de Cirugía General y Digestivo, Hospital Universitario de La Princesa, C/Diego de León, 62. 28006, Madrid, Spain.
Ángela de la HozServicio de Cirugía General y Digestivo, Hospital Universitario de La Princesa, C/Diego de León, 62. 28006, Madrid, Spain.
Laura CardeñosoServicio de Microbiología, Hospital Universitario de La Princesa, Madrid, Spain.
Diego DomingoServicio de Microbiología, Hospital Universitario de La Princesa, Madrid, Spain.
Maria Auxiliadora SemigliaServicio de Microbiología, Hospital Universitario de La Princesa, Madrid, Spain.
Hospital Universitario de La Princesa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Carbapenems are usually used in the treatment of infections caused by cephalosporin-resistant Case presentation: We present the case of a 65-year-old male diagnosed with acute lithiasic cholecystitis. Culture of the biliary prosthesis yielded a OXA-48-producing Conclusion: To our knowledge, this is the first report of OXA-48-producing

Indexed as

carbapenemcarbapenemaseHafnia alveiOXA-48

Identifiers

PMID37424558
PMCPMC10323787
OpenAlexW4381687228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.